Copertina

Long‐Term Effectiveness and Safety of Dupilumab for the Treatment of Prurigo Nodularis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Elena Ippoliti, Niccolò Gori, Giulia Guadagno, Lucia Di Nardo, Cristina Guerriero, Ketty Peris
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	International Journal of Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Intralesional Dupilumab for Recalcitrant Prurigo Nodularis
di: Stefanie M. Sand, et al.
Pubblicazione: (2025)

Long‐Term Dupilumab Efficacy and Safety in Pediatric Patients: A Real‐World Experience Over 2 Years
di: Daniele Omar Traini, et al.
Pubblicazione: (2025)

Long‐term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real‐world retrospective study
di: Andrea Chiricozzi, et al.
Pubblicazione: (2024)

Palmoplantar Skin Maceration in a Full‐Term Neonate: A Transient and Benign Condition
di: Francesco Ricci, et al.
Pubblicazione: (2026)

Clinical effectiveness of combined dupilumab and baricitinib in a patient with multi‐drug resistant severe atopic dermatitis
di: Anna Paola Lugli, et al.
Pubblicazione: (2024)

Systematic Review and Meta‐Analysis of the Efficacy and Risk of Adverse Events of Dupilumab in the Treatment of Prurigo Nodularis
di: Hicham Titou, et al.
Pubblicazione: (2025)

Renal Disease Burden in Prurigo Nodularis: A Systematic Review and Meta‐Analysis
di: Natalia Chalupczak, et al.
Pubblicazione: (2025)

Superior Clinical and Economic Value of IL ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
di: Gennaro Marco Falco, et al.
Pubblicazione: (2026)

Prevalence of Metabolic Diseases in Patients With Prurigo Nodularis: A Systematic Review and Meta‐Analysis
di: Natalia Chalupczak, et al.
Pubblicazione: (2025)

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis
di: Yuliya Valdman‐Grinshpoun, et al.
Pubblicazione: (2025)

Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis
di: Niccolò Gori, et al.
Pubblicazione: (2024)

Janus Kinase Inhibitors for the Treatment of Prurigo Nodularis: A Systematic Review of 211 Patients
di: Seyed Mohammad Vahabi, et al.
Pubblicazione: (2026)

Wound closure techniques after wide excision for hidradenitis suppurativa: a systematic review and meta‐analysis
di: Corina Ioana Cucu, et al.
Pubblicazione: (2024)

Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies
di: Giacomo Caldarola, et al.
Pubblicazione: (2024)

Baricitinib for Prurigo Nodularis: A Pilot Study on Efficacy and Safety
di: Padcha Pongcharoen, et al.
Pubblicazione: (2024)

Topical Ruxolitinib as an Effective Therapy for Vitiligo‐Like Lesions Induced by Anti‐ PD ‐1 Therapy
di: Lorenzo Maria Pinto, et al.
Pubblicazione: (2025)

Solitary cutaneous focal mucinosis: In‐vivo line‐field confocal optical coherence tomography (LC‐OCT) features correlate to histopathology
di: Gerardo Palmisano, et al.
Pubblicazione: (2024)

Effectiveness of Dupilumab and Tralokinumab in Treating Nummular Eczema
di: Francesca Barei, et al.
Pubblicazione: (2025)

No Increased Risk of Thromboembolic Events During 6‐Month Treatment With Baricitinib in Patients With Alopecia Areata
di: Giacomo Caldarola, et al.
Pubblicazione: (2025)

Real‐World Efficacy and Safety of Dupilumab for Atopic Dermatitis in the Israeli Population
di: Raz Tshuva, et al.
Pubblicazione: (2025)

Artificial Intelligence and Trichoscopy: Can AI Distinguish Between Alopecia Areata and Lichen Planopilaris?
di: Daniele Omar Traini, et al.
Pubblicazione: (2026)

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review
di: Ioannis‐Alexios Koumprentziotis, et al.
Pubblicazione: (2025)

The Efficacy of Dupilumab in Pemphigus Vulgaris
di: Foday Koroma, et al.
Pubblicazione: (2025)

Dissecting Cellulitis of the Scalp Associated With Dupilumab: A Paradoxical Neutrophilic Reaction
di: Pasquale Sorrentino, et al.
Pubblicazione: (2026)

Addressing Unmet Needs in Prurigo Nodularis: Expert Canadian Dermatology Perspectives
di: Vimal H. Prajapati, et al.
Pubblicazione: (2026)

Nemolizumab as a Novel Therapeutic Option for Refractory Prurigo Chronica Multiformis: A Case Report
di: Shota Nakayama, et al.
Pubblicazione: (2025)

Line Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) Features of Primary Cicatricial Alopecias
di: Daniele Omar Traini, et al.
Pubblicazione: (2026)

Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study
di: Dario Graceffa, et al.
Pubblicazione: (2024)

Short‐term efficacy of tildrakizumab on difficult‐to‐treat areas: a real‐world experience
di: Sara Cacciapuoti, et al.
Pubblicazione: (2024)

Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis
di: Amaia Barrutia‐Etxebarria, et al.
Pubblicazione: (2025)

Long‐Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor‐Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option
di: Giovanni Paolino, et al.
Pubblicazione: (2025)

Tirbanibulin in the Long‐Term Management of Recurrent Bowenoid Papulosis: A Retrospective Study
di: Eugenia Veronica Di Brizzi, et al.
Pubblicazione: (2025)

Line‐field confocal optical coherence tomography in alopecia areata and histopathological correlation
di: Emanuele Trovato, et al.
Pubblicazione: (2024)

Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
di: Kateryna Karpoff, et al.
Pubblicazione: (2026)

Efficacy and Safety of Tofacitinib in Patients With Refractory Prurigo Nodularis: A 16‐Week, Single‐Center, Prospective, Observational Pilot Study
di: Ru Dai, et al.
Pubblicazione: (2025)

The Use of Morphology‐Directed Targeted Immunosuppression With Dupilumab in Cutaneous Immunotherapy Related Adverse Events
di: Brittany Dulmage, et al.
Pubblicazione: (2025)

Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature
di: Luca Valtellini, et al.
Pubblicazione: (2024)

Homeopathic Vitiligo Treatments: A Safety Assessment Study
di: Kritin K. Verma, et al.
Pubblicazione: (2026)

Effective Treatment Depth of Photodynamic Therapy After Partial Debulking of Nodular Basal Cell Carcinoma
di: Ana Gabriela Salvio, et al.
Pubblicazione: (2025)

Effect of Dupilumab Therapy on Patch Test Results for Atopic Contact Dermatitis: A Systematic Review
di: Dennis Chu, et al.
Pubblicazione: (2025)